Interleukin-1 family signaling (Homo sapiens)

From WikiPathways

Revision as of 21:53, 4 March 2011 by MaintBot (Talk | contribs)
Jump to: navigation, search
1, 223353431112434, 3531918122221163031-3345, 626, 2936-388, 915208, 1324-281479, 1017cytosolIRAK1Phospho-MEK1, phospho-SEK1hp-IRAK1:TRAF6Pellino 1,2,3IL1RNATPhp-IRAK1:K6 poly-Ub oligo-TRAF6IL1 receptor complex - activated IRAK4:TOLLIPInterleukin 1 receptors:IL1RNIRAK-MMKK6ADPSCF beta-TrCP complexSCF betaTrCP complex:p-NFKB p105Phospho MKK6ATPATPInterleukin 1 receptor type 2:interleukin 1IKK complexp-Pellino-1,2,(3)IL1 receptor complex:TOLLIPhp-IRAK1:Pellino, IRAK4:Pellinohp-IRAK1:p-Pellino, IRAK4:p-PellinoInterleukin 1 receptorsp62:MEKK3IRAK2IL1:IL1R1:IL1RAP:MYD88 homodimerInterleukin-1IL1 receptor complex-activated IRAK4:TOLLIP:hp-IRAK:TRAF6ADPIL1 receptor complex- activated IRAK4:TOLLIP:hp-IRAK1IL1 receptor complex-activated IRAK4:TOLLIP:IRAK1ADPActivated TAK complexesATPUbc13/Uev1A complexIL1R1hp-IRAK1:K6-poly-Ub oligo-TRAF6:TAK1 complexIL1R2ATPPoly-K6-Ub-hp-IRAK1:IKK complexIL1R1:IL1:IL1RAPActivated IRAK4hp-IRAK1: p-Pellino-1,2,(3)Activated IKK Complexp62:MEKK3:TRAF6ADPMEK1, SEK1IL1BTRAF6IRAK4TAK1 complexADPK63-polyubiquitinADPABIN2hp-IRAK1:K6-poly-Ub oligo-TRAF6:Activated TAK1 complexTOLLIPADPATPPoly-K6-Ub-hp-IRAK1IL1 receptor complex- activated IRAK4:TOLLIP:p-IRAK1ADPhp-IRAK1, IRAK4hp-IRAK1:oligo-TRAF6p-NFkB p105ATPTPL2NFKB p105:TPL2:ABIN2mIL1RAPMYD88 homodimerNFkB p105IL1 receptor complexATPp-IRAK2Interleukin-1 receptor type 1:Interleukin-1Ub-p-NFkB1 p105


Description

Interleukin 1 (IL1) signals via Interleukin 1 receptor 1 (IL1R1), the only signaling-capable IL1 receptor. This is a single chain type 1 transmembrane protein comprising an extracellular ligand binding domain and an intracellular region called the Toll/Interleukin-1 receptor (TIR) domain that is structurally conserved and shared by other members of the two families of receptors (Xu et al. 2000). This domain is also shared by the downstream adapter molecule MyD88. IL1 binding to IL1R1 leads to the recruitment of a second receptor chain termed the IL1 receptor accessory protein (IL1RAP or IL1RAcP) enabling the formation of a high-affinity ligand-receptor complex that is capable of signal transduction. Intracellular signaling is initiated by the recruitment of MyD88 to the IL-1R1/IL1RAP complex. IL1RAP is only recruited to IL1R1 when IL1 is present; it is believed that a TIR domain signaling complex is formed between the receptor and the adapter TIR domains. The recruitment of MyD88 leads to the recruitment of Interleukin-1 receptor-associated kinase (IRAK)-1 and -4, probably via their death domains. IRAK4 then activates IRAK1, allowing IRAK1 to autophosphorylate. Both IRAK1 and IRAK4 then dissociate from MyD88 (Brikos et al. 2007) which remains stably complexed with IL-1R1 and IL1RAP. They in turn interact with Tumor Necrosis Factor Receptor (TNFR)-Associated Factor 6 (TRAF6), which is an E3 ubiquitin ligase (Deng et al. 2000). TRAF6 is then thought to auto-ubiquinate, attaching K63-polyubiquitin to itself with the assistance of the E2 conjugating complex Ubc13/Uev1a. K63-pUb-TRAF6 recruits Transforming Growth Factor (TGF) beta-activated protein kinase 1 (TAK1) in a complex with TAK1-binding protein 2 (TAB2) and TAB3, which both contain nuclear zinc finger motifs that interact with K63-polyubiquitin chains (Ninomiya-Tsuji et al. 1999). This activates TAK1, which then activates inhibitor of NF-kappaB (IkappaB) kinase 2 (IKK2 or IKKB) within the IKK complex, the kinase responsible for phosphorylation of IkappaB. The IKK complex also contains the scaffold protein NF-kappa B essential modulator (NEMO). TAK1 also couples to the upstream kinases for p38 and c-jun N-terminal kinase (JNK). IRAK1 undergoes K63-linked polyubiquination; Pellino E3 ligases are important in this process. (Butler et al. 2007; Ordureau et al. 2008). The activity of these proteins is greatly enhanced by IRAK phosphorylation (Schauvliege et al. 2006), leading to K63-linked polyubiquitination of IRAK1. This recruits NEMO to IRAK1, with NEMO binding to polyubiquitin (Conze et al. 2008).

TAK1 activates IKKB (and IKK), resulting in phosphorylation of the inhibitory IkB proteins and enabling translocation of NFkB to the nucleus; IKKB also phosphorylates NFkB p105, leading to its degradation and the subsequent release of active TPL2 that triggers the extracellular-signal regulated kinase (ERK)1/2 MAPK cascade. TAK1 can also trigger the p38 and JNK MAPK pathways via activating the upstream MKKs3, 4 and 6. The MAPK pathways activate a number of downstream kinases and transcription factors that co-operate with NFkB to induce the expression of a range of TLR/IL-1R-responsive genes. There are reports suggesting that IL1 stimulation increases nuclear localization of IRAK1 (Bol et al. 2000) and that nuclear IRAK1 binds to the promoter of NFkB-regulated gene and IkBa, enhancing binding of the NFkB p65 subunit to NFkB responsive elements within the IkBa promoter. IRAK1 is required for IL1-induced Ser-10 phosphorylation of histone H3 in vivo (Liu et al. 2008). However, details of this aspect of IRAK1 signaling mechanisms remain unclear.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Sharma S, Kulk N, Nold MF, Gräf R, Kim SH, Reinhardt D, Dinarello CA, Bufler P.; ''The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines.''; PubMed Europe PMC Scholia
  2. Wu C, Ghosh S.; ''Differential phosphorylation of the signal-responsive domain of I kappa B alpha and I kappa B beta by I kappa B kinases.''; PubMed Europe PMC Scholia
  3. Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J.; ''Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.''; PubMed Europe PMC Scholia
  4. Cheng H, Addona T, Keshishian H, Dahlstrand E, Lu C, Dorsch M, Li Z, Wang A, Ocain TD, Li P, Parsons TF, Jaffee B, Xu Y.; ''Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop.''; PubMed Europe PMC Scholia
  5. Goldstein MH, Martel JR, Sall K, Goldberg DF, Abrams M, Rubin J, Sheppard J, Tauber J, Korenfeld M, Agahigian J, Durham TA, Furfine E.; ''Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease.''; PubMed Europe PMC Scholia
  6. Arch RH, Gedrich RW, Thompson CB.; ''Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death.''; PubMed Europe PMC Scholia
  7. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE.; ''Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.''; PubMed Europe PMC Scholia
  8. Gilmore TD.; ''Introduction to NF-kappaB: players, pathways, perspectives.''; PubMed Europe PMC Scholia
  9. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG.; ''Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.''; PubMed Europe PMC Scholia
  10. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z.; ''MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.''; PubMed Europe PMC Scholia
  11. Dower SK, Kronheim SR, Hopp TP, Cantrell M, Deeley M, Gillis S, Henney CS, Urdal DL.; ''The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.''; PubMed Europe PMC Scholia
  12. Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, Lotz-Havla AS, Gersting SW, Cho SX, Lao JC, Ellisdon AM, Rotter B, Azam T, Mangan NE, Rossello FJ, Whisstock JC, Bufler P, Garlanda C, Mantovani A, Dinarello CA, Nold MF, Nold MF.; ''IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.''; PubMed Europe PMC Scholia
  13. Spencer E, Jiang J, Chen ZJ.; ''Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP.''; PubMed Europe PMC Scholia
  14. Shi P, Zhu S, Lin Y, Liu Y, Liu Y, Chen Z, Shi Y, Qian Y.; ''Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.''; PubMed Europe PMC Scholia
  15. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K.; ''Interleukin 1 signaling occurs exclusively via the type I receptor.''; PubMed Europe PMC Scholia
  16. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA.; ''IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.''; PubMed Europe PMC Scholia
  17. Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X.; ''Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.''; PubMed Europe PMC Scholia
  18. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y.; ''Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.''; PubMed Europe PMC Scholia
  19. Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE.; ''Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling.''; PubMed Europe PMC Scholia
  20. Towne JE, Renshaw BR, Douangpanya J, Lipsky BP, Shen M, Gabel CA, Sims JE.; ''Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.''; PubMed Europe PMC Scholia
  21. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, Matsumoto K.; ''TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.''; PubMed Europe PMC Scholia
  22. Carter DB, Deibel MR, Dunn CJ, Tomich CS, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN.; ''Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein.''; PubMed Europe PMC Scholia
  23. van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG, Joosten LA, van der Meer JW, Hao R, Kalabokis V, Dinarello CA.; ''IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist.''; PubMed Europe PMC Scholia
  24. Palomo J, Dietrich D, Martin P, Palmer G, Gabay C.; ''The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.''; PubMed Europe PMC Scholia
  25. Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA, Wiesmann C, Bazan JF, Fairbrother WJ.; ''Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.''; PubMed Europe PMC Scholia
  26. Butler MP, Hanly JA, Moynagh PN.; ''Pellino3 is a novel upstream regulator of p38 MAPK and activates CREB in a p38-dependent manner.''; PubMed Europe PMC Scholia
  27. Seckinger P, Klein-Nulend J, Alander C, Thompson RC, Dayer JM, Raisz LG.; ''Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.''; PubMed Europe PMC Scholia
  28. Moynagh PN.; ''The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling.''; PubMed Europe PMC Scholia
  29. Gabay C, Towne JE.; ''Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.''; PubMed Europe PMC Scholia
  30. Lang V, Symons A, Watton SJ, Janzen J, Soneji Y, Beinke S, Howell S, Ley SC.; ''ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability.''; PubMed Europe PMC Scholia
  31. Bulau AM, Nold MF, Li S, Nold-Petry CA, Fink M, Mansell A, Schwerd T, Hong J, Rubartelli A, Dinarello CA, Bufler P.; ''Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses.''; PubMed Europe PMC Scholia
  32. Nold MF, Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA.; ''IL-37 is a fundamental inhibitor of innate immunity.''; PubMed Europe PMC Scholia
  33. Debets R, Timans JC, Homey B, Zurawski S, Sana TR, Lo S, Wagner J, Edwards G, Clifford T, Menon S, Bazan JF, Kastelein RA.; ''Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2.''; PubMed Europe PMC Scholia
  34. Windheim M, Stafford M, Peggie M, Cohen P.; ''Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase.''; PubMed Europe PMC Scholia
  35. Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, Bachelerie F, Arenzana-Seisdedos F, Benarous R.; ''Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP.''; PubMed Europe PMC Scholia
  36. Nakamura K, Kimple AJ, Siderovski DP, Johnson GL.; ''PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation.''; PubMed Europe PMC Scholia
  37. Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P.; ''Suppression of innate inflammation and immunity by interleukin-37.''; PubMed Europe PMC Scholia
  38. Stafford MJ, Morrice NA, Peggie MW, Cohen P.; ''Interleukin-1 stimulated activation of the COT catalytic subunit through the phosphorylation of Thr290 and Ser62.''; PubMed Europe PMC Scholia
  39. Smith H, Peggie M, Campbell DG, Vandermoere F, Carrick E, Cohen P.; ''Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4.''; PubMed Europe PMC Scholia
  40. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW.; ''The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.''; PubMed Europe PMC Scholia
  41. Butler MP, Hanly JA, Moynagh PN.; ''Kinase-active interleukin-1 receptor-associated kinases promote polyubiquitination and degradation of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-protein isopeptide ligases.''; PubMed Europe PMC Scholia
  42. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M.; ''Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.''; PubMed Europe PMC Scholia
  43. Born TL, Thomassen E, Bird TA, Sims JE.; ''Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling.''; PubMed Europe PMC Scholia
  44. Waterfield MR, Zhang M, Norman LP, Sun SC.; ''NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.''; PubMed Europe PMC Scholia
  45. Huang J, Gao X, Li S, Cao Z.; ''Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.''; PubMed Europe PMC Scholia
  46. Luo C, Shu Y, Luo J, Liu D, Huang DS, Han Y, Chen C, Li YC, Zou JM, Qin J, Wang Y, Li D, Wang SS, Zhang GM, Chen J, Feng ZH.; ''Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells.''; PubMed Europe PMC Scholia
  47. Dinarello CA.; ''Immunological and inflammatory functions of the interleukin-1 family.''; PubMed Europe PMC Scholia
  48. Cao Z, Henzel WJ, Gao X.; ''IRAK: a kinase associated with the interleukin-1 receptor.''; PubMed Europe PMC Scholia
  49. Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
  50. Rothwarf DM, Zandi E, Natoli G, Karin M.; ''IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.''; PubMed Europe PMC Scholia
  51. Hattori K, Hatakeyama S, Shirane M, Matsumoto M, Nakayama K.; ''Molecular dissection of the interactions among IkappaBalpha, FWD1, and Skp1 required for ubiquitin-mediated proteolysis of IkappaBalpha.''; PubMed Europe PMC Scholia
  52. Kishore N, Huynh QK, Mathialagan S, Hall T, Rouw S, Creely D, Lange G, Caroll J, Reitz B, Donnelly A, Boddupalli H, Combs RG, Kretzmer K, Tripp CS.; ''IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2.''; PubMed Europe PMC Scholia
  53. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A.; ''Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.''; PubMed Europe PMC Scholia
  54. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ.; ''TAK1 is a ubiquitin-dependent kinase of MKK and IKK.''; PubMed Europe PMC Scholia
  55. Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K, Baeuerle PA, Scheidereit C.; ''The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.''; PubMed Europe PMC Scholia
  56. Pavlowsky A, Zanchi A, Pallotto M, Giustetto M, Chelly J, Sala C, Billuart P.; ''Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions.''; PubMed Europe PMC Scholia
  57. Ordureau A, Smith H, Windheim M, Peggie M, Carrick E, Morrice N, Cohen P.; ''The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1.''; PubMed Europe PMC Scholia
  58. Cohen S, Achbert-Weiner H, Ciechanover A.; ''Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.''; PubMed Europe PMC Scholia
  59. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T.; ''Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.''; PubMed Europe PMC Scholia
  60. Pan G, Risser P, Mao W, Baldwin DT, Zhong AW, Filvaroff E, Yansura D, Lewis L, Eigenbrot C, Henzel WJ, Vandlen R.; ''IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp.''; PubMed Europe PMC Scholia
  61. Strack P, Caligiuri M, Pelletier M, Boisclair M, Theodoras A, Beer-Romero P, Glass S, Parsons T, Copeland RA, Auger KR, Benfield P, Brizuela L, Rolfe M.; ''SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.''; PubMed Europe PMC Scholia
  62. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, Ohta T, Ikeda M, Ikegami H, Kurimoto M.; ''Purification and characterization of the human interleukin-18 receptor.''; PubMed Europe PMC Scholia
  63. Chaitidis P, O'Donnell V, Kuban RJ, Bermudez-Fajardo A, Ungethuem U, Kühn H.; ''Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13.''; PubMed Europe PMC Scholia
  64. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP.; ''Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.''; PubMed Europe PMC Scholia
  65. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J, Volpe F.; ''Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.''; PubMed Europe PMC Scholia
  66. Shi Y, Massagué J.; ''Mechanisms of TGF-beta signaling from cell membrane to the nucleus.''; PubMed Europe PMC Scholia
  67. Kishimoto K, Matsumoto K, Ninomiya-Tsuji J.; ''TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop.''; PubMed Europe PMC Scholia
  68. Adhikari A, Xu M, Chen ZJ.; ''Ubiquitin-mediated activation of TAK1 and IKK.''; PubMed Europe PMC Scholia
  69. Mora J, Schlemmer A, Wittig I, Richter F, Putyrski M, Frank AC, Han Y, Jung M, Ernst A, Weigert A, Brüne B.; ''Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses.''; PubMed Europe PMC Scholia
  70. Bufler P, Azam T, Gamboni-Robertson F, Reznikov LL, Kumar S, Dinarello CA, Kim SH.; ''A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity.''; PubMed Europe PMC Scholia
  71. Strelow A, Kollewe C, Wesche H.; ''Characterization of Pellino2, a substrate of IRAK1 and IRAK4.''; PubMed Europe PMC Scholia
  72. Conze DB, Wu CJ, Thomas JA, Landstrom A, Ashwell JD.; ''Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.''; PubMed Europe PMC Scholia
  73. Brough D, Rothwell NJ.; ''Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death.''; PubMed Europe PMC Scholia
  74. Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y, Saitoh T, Kawai T, Takeuchi O, Akira S.; ''Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.''; PubMed Europe PMC Scholia
  75. Gottipati S, Rao NL, Fung-Leung WP.; ''IRAK1: a critical signaling mediator of innate immunity.''; PubMed Europe PMC Scholia
  76. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A.; ''IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.''; PubMed Europe PMC Scholia
  77. Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, Gao W, Gambotto A, Lotze MT.; ''Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.''; PubMed Europe PMC Scholia
  78. Arend WP, Gabay C.; ''Physiologic role of interleukin-1 receptor antagonist.''; PubMed Europe PMC Scholia
  79. Kollewe C, Mackensen AC, Neumann D, Knop J, Cao P, Li S, Wesche H, Martin MU.; ''Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling.''; PubMed Europe PMC Scholia
  80. Cheung PC, Nebreda AR, Cohen P.; ''TAB3, a new binding partner of the protein kinase TAK1.''; PubMed Europe PMC Scholia
  81. Belich MP, Salmerón A, Johnston LH, Ley SC.; ''TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.''; PubMed Europe PMC Scholia
  82. Beinke S, Deka J, Lang V, Belich MP, Walker PA, Howell S, Smerdon SJ, Gamblin SJ, Ley SC.; ''NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.''; PubMed Europe PMC Scholia
  83. Handoyo H, Stafford MJ, McManus E, Baltzis D, Peggie M, Cohen P.; ''IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.''; PubMed Europe PMC Scholia
  84. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ, Wang RF.; ''NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.''; PubMed Europe PMC Scholia
  85. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI.; ''A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.''; PubMed Europe PMC Scholia
  86. Cho J, Melnick M, Solidakis GP, Tsichlis PN.; ''Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.''; PubMed Europe PMC Scholia
  87. Muroi M, Tanamoto K.; ''TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB.''; PubMed Europe PMC Scholia
  88. Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M.; ''Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.''; PubMed Europe PMC Scholia
  89. Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
  90. Li S, Strelow A, Fontana EJ, Wesche H.; ''IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.''; PubMed Europe PMC Scholia
  91. Arend WP, Palmer G, Gabay C.; ''IL-1, IL-18, and IL-33 families of cytokines.''; PubMed Europe PMC Scholia
  92. Brikos C, Wait R, Begum S, O'Neill LA, Saklatvala J.; ''Mass spectrometric analysis of the endogenous type I interleukin-1 (IL-1) receptor signaling complex formed after IL-1 binding identifies IL-1RAcP, MyD88, and IRAK-4 as the stable components.''; PubMed Europe PMC Scholia
  93. Roget K, Ben-Addi A, Mambole-Dema A, Gantke T, Yang HT, Janzen J, Morrice N, Abbott D, Ley SC.; ''IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400.''; PubMed Europe PMC Scholia
  94. Grimsby S, Jaensson H, Dubrovska A, Lomnytska M, Hellman U, Souchelnytskyi S.; ''Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity.''; PubMed Europe PMC Scholia
  95. Heissmeyer V, Krappmann D, Hatada EN, Scheidereit C.; ''Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.''; PubMed Europe PMC Scholia
  96. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV.; ''TRAF6 is a signal transducer for interleukin-1.''; PubMed Europe PMC Scholia
  97. Lang V, Janzen J, Fischer GZ, Soneji Y, Beinke S, Salmeron A, Allen H, Hay RT, Ben-Neriah Y, Ley SC.; ''betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.''; PubMed Europe PMC Scholia
  98. Khan JA, Brint EK, O'Neill LA, Tong L.; ''Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114671view16:14, 25 January 2021ReactomeTeamReactome version 75
113118view11:18, 2 November 2020ReactomeTeamReactome version 74
112352view15:28, 9 October 2020ReactomeTeamReactome version 73
101253view11:14, 1 November 2018ReactomeTeamreactome version 66
100792view20:42, 31 October 2018ReactomeTeamreactome version 65
100334view19:19, 31 October 2018ReactomeTeamreactome version 64
99879view16:02, 31 October 2018ReactomeTeamreactome version 63
99436view14:37, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99023view13:07, 24 October 2018DeSlOntology Term : 'signaling pathway' added !
99022view13:06, 24 October 2018DeSlOntology Term : 'kinase mediated signaling pathway' added !
94504view09:20, 14 September 2017Mkutmonreactome version 61
86604view09:22, 11 July 2016ReactomeTeamreactome version 56
83129view10:03, 18 November 2015ReactomeTeamVersion54
81471view13:00, 21 August 2015ReactomeTeamVersion53
76943view08:21, 17 July 2014ReactomeTeamFixed remaining interactions
76648view12:02, 16 July 2014ReactomeTeamFixed remaining interactions
75978view10:03, 11 June 2014ReactomeTeamRe-fixing comment source
75681view11:01, 10 June 2014ReactomeTeamReactome 48 Update
75036view13:54, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74838view10:06, 30 April 2014ReactomeTeamReactome46
74680view08:45, 30 April 2014ReactomeTeamReactome46
44873view10:01, 6 October 2011MartijnVanIerselOntology Term : 'interleukin-1 signaling pathway' added !
44872view10:00, 6 October 2011MartijnVanIerselOntology Term : 'PW:0000512' removed !
44869view09:59, 6 October 2011MartijnVanIerselOntology Term : 'Interleukin mediated signaling pathway' added !
42058view21:53, 4 March 2011MaintBotAutomatic update
39865view05:53, 21 January 2011MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ABIN2 ProteinQ8NFZ5 (UniProt)
ADP Metabolite16761 (ChEBI)
ATP Metabolite15422 (ChEBI)
Activated IKK

Complex

ComplexREACT_7826 (Reactome)
Activated IRAK4 ProteinQ9NWZ3 (UniProt)
Activated TAK

complexes

ComplexREACT_23279 (Reactome)
IKK complex ComplexREACT_7693 (Reactome)
IL1 receptor

complex

ComplexREACT_23029 (Reactome)
IL1 receptor

complex- activated IRAK4:TOLLIP:hp- IRAK1

ComplexREACT_23332 (Reactome)
IL1 receptor

complex- activated IRAK4:TOLLIP:p- IRAK1

ComplexREACT_23087 (Reactome)
IL1 receptor

complex-activated IRAK4:TOLLIP:IRAK1

ComplexREACT_22771 (Reactome)
IL1 receptor

complex-activated IRAK4:TOLLIP:hp- IRAK:TRAF6

ComplexREACT_22757 (Reactome)
IL1 receptor

complex:TOLLIP

ComplexREACT_23348 (Reactome)
IL1 receptor complex

- activated IRAK4: TOLLIP

ComplexREACT_23002 (Reactome)
IL1:IL1R1:IL1RAP:

MYD88 homodimer

ComplexREACT_23167 (Reactome)
IL1B ProteinP01584 (UniProt)
IL1R1 ProteinP14778 (UniProt)
IL1R1:IL1:IL1RAP ComplexREACT_22656 (Reactome)
IL1R2 ProteinP27930 (UniProt)
IL1RN ProteinP18510 (UniProt)
IRAK-M ProteinQ9Y616 (UniProt)
IRAK1 ProteinP51617 (UniProt)
IRAK2 ProteinO43187 (UniProt)
IRAK4 ProteinQ9NWZ3 (UniProt)
Interleukin 1

receptor type 2: interleukin 1

ComplexREACT_22786 (Reactome)
Interleukin 1

receptors

ProteinREACT_23342 (Reactome)
Interleukin 1

receptors:IL1RN

ComplexREACT_22878 (Reactome)
Interleukin-1 ProteinREACT_22576 (Reactome)
Interleukin-1

receptor type 1: Interleukin-1

ComplexREACT_23118 (Reactome)
K63-polyubiquitin UnknownREACT_21645 (Reactome)
MEK1, SEK1 ProteinREACT_22657 (Reactome)
MKK6 ProteinP52564 (UniProt)
MYD88 homodimer ComplexREACT_14253 (Reactome)
NFKB p105:TPL2:

ABIN2

ComplexREACT_22747 (Reactome)
NFkB p105 ProteinP19838 (UniProt)
Pellino 1,2,3 ProteinREACT_22780 (Reactome)
Phospho MKK6 ProteinP52564 (UniProt)
Phospho-MEK1,

phospho-SEK1

ProteinREACT_22945 (Reactome)
Poly-K6-Ub-

hp-IRAK1

ComplexREACT_23323 (Reactome)
Poly-K6-Ub-hp-

IRAK1:IKK complex

ComplexREACT_22624 (Reactome)
SCF beta-TrCP

complex

ComplexREACT_22981 (Reactome)
SCF betaTrCP

complex:p-NFKB p105

ComplexREACT_22646 (Reactome)
TAK1 complex ComplexREACT_22633 (Reactome)
TOLLIP ProteinQ9H0E2 (UniProt)
TPL2 ProteinP41279 (UniProt)
TRAF6 ProteinQ9Y4K3 (UniProt)
Ub-p-NFkB1 p105 ProteinP19838 (UniProt)
Ubc13/Uev1A

complex

ComplexREACT_12995 (Reactome)
hp-IRAK1, IRAK4 ProteinREACT_23241 (Reactome)
hp-IRAK1: p-Pellino-

1,2,(3)

ComplexREACT_22866 (Reactome)
hp-IRAK1:K6 poly-

Ub oligo-TRAF6

ComplexREACT_23272 (Reactome)
hp-IRAK1:K6-poly-

Ub oligo-TRAF6: Activated TAK1 complex

ComplexREACT_23314 (Reactome)
hp-IRAK1:K6-poly-

Ub oligo-TRAF6: TAK1 complex

ComplexREACT_22797 (Reactome)
hp-IRAK1:Pellino,

IRAK4:Pellino

ComplexREACT_23330 (Reactome)
hp-IRAK1:TRAF6 ComplexREACT_22529 (Reactome)
hp-IRAK1:oligo-

TRAF6

ComplexREACT_22793 (Reactome)
hp-IRAK1:p-Pellino,

IRAK4:p-Pellino

ComplexREACT_22769 (Reactome)
mIL1RAP ProteinQ9NPH3-1 (UniProt)
p-IRAK2 ProteinO43187 (UniProt)
p-NFkB p105 ProteinP19838 (UniProt)
p-Pellino-1,2,(3) ProteinREACT_22733 (Reactome)
p62:MEKK3 ComplexREACT_23211 (Reactome)
p62:MEKK3:TRAF6 ComplexREACT_23141 (Reactome)

Annotated Interactions

No annotated interactions

Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP1839"
Personal tools